Knowledge Center

67 Results Found

In this informational session, Karen Conway discusses her research with the FDA on value and the UDI. Mike Schiller joins the conversation by adding the actions AHRMM is taking with the Learning UDI Community to identify adoption practices and move beyond compliance.
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Data Quality Workshops during four conferences in 2017. During these workshops, conference attendees had the opportunity to voice their opinions on the state of UDI data quality, hurdles to UDI adoption and what recommended practices are necessary for providers and suppliers to effectively capture the UDI and use it in meaningful ways.  
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the value of UDI adoption in health care organizations. AHRMM’s Mike Schiller, senior director of supply chain, joins the conversation by describing the actions AHRMM is taking with the Learning UDI Community (LUC) to identify adoption practices and move beyond compliance. 
Susan Morris, CMRP, FAHRMM, health care executive, Cerner Corporation, explains the different parts of the Unique Device Identifier (UDI) and which part should go into the Item Master.  This webcast walks through the three FDA-accredited issuing agencies that assign UDIs and explains what information is in the different barcodes and how to read them both electronically and by human sight.
CASE STUDY PARTICIPANTS: Lawrence Gossman, AVP, Supply Chain, Fran Sercer, MSN RN, Associate Director of Interventional Services, Anita Sears, Director of Supply Chain, Eskenazi Health
WORK GROUP TITLE: UDI Capture Work GroupCASE STUDY PARTICIPANTS: Sandi Michel, MPMP, ITIL, CLSSBB, Director of Supply Chain Systems and Quality, the Office of Data Standards & Interoperability for Franciscan Missionaries of Our Lady Health System (FMOLHS)CASE STUDY ORGANIZATION:
An update on current FDA and Congressional activity on independent service for reusable medical devices and the potential impact on your costs and level of service. Learn what you can do to get ready for potential changes that could affect your organization.
WORK GROUP TITLE: UDI Capture Work GroupCASE STUDY PARTICIPANTS: •    Tonya Gilliam and Lana Glover, EPIC Team •    Terry Hays and Alex Monday, IT Team •    Doug Barnhart, OR Team •    Tom Stenger, Johnny Dennis and Justin Holstead, Supply Chain Team •    Lorette Hefley, Revenue Cycle TeamCASE STUDY ORGANIZATION:
In part one, we explore the reasons why the FDA created the (UOU) Unit of Use.
In the third part of the the FDA Unique Device Identification (UDI) “Unit of Use” (UOU) webcast series, we cover several potential use cases for the FDA UDI UOU identifier.
In part two of the FDA Unique Device Identification (UDI) Unit of Use (UOU) webcast series, we cover the FDA definition of the term, Unit of Use.
From a supply chain perspective, the use of UDIs will help with the visibility of supplies throughout the continuum of care. By Dennis Mullins, MBA, CMRP Download Article
WORK GROUP TITLE: UDI Capture Work GroupCASE STUDY PARTICIPANTS: Wendy Watson, OR Supply Chain Manager at University Health NetworkCASE STUDY ORGANIZATION: University Health Network (UHN) serves the residents of Toronto, Ontario, Canada’s largest city, and the surrounding communities. UHN is comprised of 10 program areas spread across four hospitals and eight sites. It has $2B in revenues, 1,200 patient beds and its surgeons perform 24,000 surgical procedures each year.
WORK GROUP TITLE: UDI Capture Work GroupCASE STUDY PARTICIPANTS: Becky Ashin, Vice President, Advanced Orthopaedic Center, University of Tennessee Medical Center Beth Kaylor, RN Clinical Director, Innovation, DeRoyal IndustriesCASE STUDY ORGANIZATION:
WORK GROUP TITLE: UDI Capture Work GroupCASE STUDY PARTICIPANTS: James Phillips, Consulting Manager, DSI, the Office of Data Standards and Interoperability, Franciscan Missionaries of Our Lady Health System (FMOLHS)CASE STUDY ORGANIZATION: